Iowa House File 2635 (HF2635) is a healthcare reform bill that was passed by the Iowa Legislature and signed by the Governor. The bill states that AI cannot be the sole basis for denying, delaying, or downgrading medically necessary services. Human clinical review remains required.
The law is not written only for behavioral health. It is a broader health insurance and utilization review reform bill to protect patients. But several of its provisions speak directly to long-standing problems experienced by mental health providers, substance use disorder programs, recovery centers, and the patients they serve.
Recovery often begins in a narrow window. A patient asks for help. A family finds a treatment program. A clinician identifies the right level of care. In behavioral health and substance use recovery, that moment can be fragile. When prior authorization delays treatment, the issue is not just administrative. It can affect whether a person starts care, stays engaged, or returns to use before support is in place.
That is why Iowa’s HF2635 is an important step in drawing a line on how AI can be deployed, which other states should follow.
First, HF2635 brings more accountability to prior authorization decisions. The bill restricts the use of artificial intelligence by preventing utilization review organizations from using an AI-based system as the sole basis to deny, delay, or downgrade a prior authorization request based on medical necessity. In behavioral health, where patient history, clinical presentation, relapse risk, toxicology findings, co-occurring conditions, and social context all matter, this is critical. Care decisions should not be reduced to an automated rejection without meaningful clinical review and human accountability.
Second, the law requires denials or downgrades to be reviewed by a qualified reviewer or clinical peer with relevant specialty experience. Behavioral health care is complex. A patient needing residential treatment, intensive outpatient care, medication for opioid use disorder, crisis stabilization, or ongoing recovery support should not have that care downgraded by someone without the appropriate clinical background. Peer review adds a layer of fairness and clinical relevance.
Third, HF2635 requires clearer written explanations for denials and downgrades, including the specific criteria used. For providers, this helps reduce the “black box” nature of prior authorization. For patients, it creates a clearer path to appeal. For recovery programs, it can make the difference between spending days chasing vague denials and quickly submitting the right clinical documentation.
The timing matters. Behavioral health and substance use disorder treatment cannot always wait. Delays can interrupt medication adherence, postpone therapy, disrupt continuity of care, and increase the risk of relapse, emergency department use, hospitalization, or overdose. For patients in recovery, even a few days of uncertainty can have real consequences.
“Every unnecessary delay creates risk for patients, families, and providers. HF2635 helps move prior authorization in the right direction by creating greater accountability. One can imagine a scenario where an AI model that is optimized for cost reduction and missing patient context routinely denies care.” — Jibreel Sarij, CEO, Acutis Diagnostics
HF2635 should also be viewed in the larger national context. Federal mental health parity rules already recognize that prior authorization can function as a nonquantitative treatment limitation. In plain terms, insurers should not make it harder to access mental health or substance use disorder care than medical or surgical care. Iowa’s law adds state-level structure around that principle by requiring more transparent, clinically grounded review.
For behavioral health and recovery providers, the law reinforces an important message: documentation matters. Clear clinical notes, medical necessity rationale, treatment history, medication records, toxicology data when appropriate, relapse risk indicators, and objective evidence can all support authorization and appeals. Strong documentation helps ensure that the payer sees the full clinical picture, not just a checkbox.
“Behavioral health and recovery care require timely, clinically informed decisions. HF2635 strengthens the role of qualified review, transparent criteria, and objective clinical documentation” — David Goldberg, Chief Compliance Officer, Acutis Diagnostics
For patients and families, the law represents something simpler: a fairer process. It does not eliminate every prior authorization barrier, and it does not guarantee instant approval. But it pushes the system toward greater transparency, faster workflows, human clinical review, and stronger accountability.
Recovery is hard enough. People seeking help should not lose momentum because of opaque denials, automated decisions, or unnecessary administrative delays. Iowa’s HF2635 matters because it recognizes that access to care is part of care itself. For behavioral health and recovery, that distinction can be lifesaving.
